New senate bill cuts proposed device industry fee
This article was originally published in SRA
The US Senate has voted 60-39 in favour of holding a debate on a healthcare reform bill unveiled last week by Harry Reid (Democrat – Nevada), marking a significant victory for the Senate majority leader as well as for President Barack Obama1. Most notably, this latest bill would impose an annual fee of $2 billion on the medical devices industry, whereas earlier Senate versions had proposed a $4 billion annual fee2.
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.